Sichenzia Ross Friedman Ference LLP Advises Laidlaw & Company on $6.72 million Secondary Public Offering of Novabay Pharmaceuticals, Inc.
NEW YORK, March 25, 2014 (GLOBE NEWSWIRE) — New York- based securities law firm, Sichenzia Ross Friedman Ference LLP announced that it has represented Laidlaw & Company (UK) Ltd. as sole underwriter in a $6.72 million secondary public offering for Novabay Pharmaceuticals, Inc. (“NBY” NYSE MKT). The underwriting was pursuant to a prospectus supplement to an effective S-3 registration statement. The offering consisted of 5,600,000 shares of common stock and 18 month warrants to purchase 1,400,000 shares of common stock at combined offering price of $1.20 . The Sichenzia Ross Friedman Ference LLP team was led by partners Richard Friedman and Stephen Cohen.
Visit SRF's LinkedIn page
Latest posts by Sichenzia Ross Ference LLP (see all)
- Sichenzia Ross Ference Closes $180 Million Real Estate Portfolio Acquisition on Behalf of Client - April 20, 2019
- Partner Mendy Piekarski Achieves Complete Dismissal for SRF Client - April 19, 2019
- Sichenzia Ross Ference LLP Represents Quest Solutions, Inc. in $5 Million Private Placement - April 10, 2019